Publications 2018

Banas, B., Steubl, D., Renders, L., Chittka, D., Banas, M. C., Wekerle, T., Koch, M., Witzke, O., Muhlfeld, A., Sommerer, C., Habicht, A., Hugo, C., Hunig, T., Lindemann, M., Schmidt, T., Rascle, A., Barabas, S., Deml, L., Wagner, R., Kramer, B. K. and Kruger, B. 2017. Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study. Transpl Int;submitted; 10.1111/tri.13110

Pilat N, Sabler P, Klaus C, et al. Blockade of adhesion molecule lymphocyte function-associated antigen-1 improves long-term heart allograft survival in mixed chimeras.  J Heart Lung Transplant;37(9):1119-30; 10.1016/j.healun.2018.03.016

Wekerle T, Oberbauer R. Transplant International in a nutshell. Transpl Int. Jan 2018;31(1):5.

Bigenzahn, S., Juergens, B., Mahr, B., Pratschke, J., Koenigsrainer, A., Becker, T., Fuchs, D., Brandacher, G., Kainz, A., Muehlbacher, F., Wekerle, T. 2018. No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients. Clin Exp Immunol;192(2):233-41.

Schwarz, C., Mahr, B., Muckenhuber, M., Wekerle, T. 2018. Belatacept/CTLA4Ig: an update and critical appraisal of preclinical and clinical results. Expert Rev Clin Immunol:1-10.

Pilat, N., Mahr, B., Gattringer, M., Baranyi, U. and Wekerle, T. 2018. CTLA4Ig Improves Murine iTreg Induction via TGFbeta and Suppressor Function In Vitro. J Immunol Res;2018:2484825; 10.1155/2018/2484825

Schwarz, C.and Wekerle, T. 2018. Blocking CD40/CD40L for Chimerism-Based Tolerance: Lost in Translation? Transplantation;Online First; 10.1097/TP.0000000000002418